According to the expression of immune checkpoint genes (Supplementary Figure S4), partial immune checkpoint genes were significantly different between the two groups.CD86, whose expression was significantly lower in cluster2 than in cluster1, exerts anti-tumor effects by binding to CD28, inducing T cells to continue proliferating and differentiating into effector T cells (26). The gene discussed is CD86; the disease is neoplasm.